LJPC लाइव सिग्नल्स | Getagraph.com के साथ लाभ को अधिकतम करें

Live Chart Being Loaded With Signals

Commentary (16 Aug 2022 @ 01:30):

La Jolla Pharmaceutical Company engages in the development and commercialization of therapies that improve outcomes in patients suffering from life-threatening diseases...

Stats
आज की मात्रा	960 928
औसत मात्रा	0
बाजार मूल्य	0.00
EPS	$0.0766 ( Q2 \| 2022-08-15 )
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	47.62 (Sector) 42.63 (Industry) 24.32
ATR14	$0.137 (2.20%)

AADI -2.37%

ABCL 1.65%

ABCM 0.04%

ABEO -2.84%

ABIO -0.98%

ABOS 0.70%

ABSI 2.72%

ABUS -2.46%

ABVX -3.53%

ACAD -0.80%

ACER -17.95%

ACET -3.40%

ACGN 1.29%

ACHL -4.15%

ACHV -1.73%

ACIU -0.50%

ACLX -0.20%

ACRV -4.79%

ACST -1.63%

ACXP 0.65%

ADAG 4.64%

ADAP -2.80%

ADGI 0.87%

ADIL 0.54%

ADMA -2.50%

ADPT -0.30%

ADTX -3.47%

ADVM -3.18%

ADXN -1.60%

AEON -3.74%

AEZS -3.51%

AFMD -1.40%

AGEN -1.61%

AGIO -1.88%

AGLE 6.66%

AGTC 0.00%

AIKI 0.85%

AIMDW -13.88%

AKBA -3.14%

AKRO -2.79%

AKTX 4.08%

AKUS 0.00%

ALBO 0.00%

ALDX -2.41%

ALEC -3.86%

ALGS -2.41%

ALKS -0.21%

ALLK -8.90%

ALLO -6.67%

ALLR -4.01%

ALNA 3.16%

ALNY 1.57%

ALPN 0.02%

ALPX 0.00%

ALRN -1.67%

ALT -9.59%

ALVR 0.92%

ALXN 0.00%

ALXO -10.81%

ALZN 5.07%

AMRN 0.26%

AMTI -3.13%

ANAB 0.42%

ANEB -1.52%

ANGN 0.00%

ANIX -1.62%

ANL -6.60%

ANNX -0.65%

ANPC -3.15%

APGE -0.96%

APGN 8.48%

APGNW 30.65%

APLM 1.56%

APLS 0.10%

APLT -3.84%

APM -1.47%

APOP 0.38%

APRE 2.29%

APTO 4.70%

APTX 3.17%

APVO 0.18%

ARAV -13.39%

ARCT -3.99%

ARDS -14.23%

ARDX -0.91%

ARGX -0.93%

ARNA 0.00%

ARPO -0.90%

ARQT -0.31%

ARTL -2.50%

ARTLW 0.00%

ARVN 5.19%

ARWR -1.82%

ASLN -3.18%

ASMB -3.70%

ASND -1.27%

ATAI -1.48%

ATHA 5.94%

ATHE 1.12%

ATHX -33.50%

ATNF 0.98%

ATOS 4.85%

ATRA -2.88%

ATXI 1.93%

ATXS -1.00%

AUPH -0.99%

AURA -0.15%

AUTL -1.87%

AVBP -2.79%

AVEO 0.00%

AVIR -0.44%

AVRO -1.41%

AVTE -5.17%

AVTX -1.25%

AVXL -2.84%

AXLA 0.00%

AXSM -1.70%

AYLA 0.00%

AZRX 2.07%

BBI 2.17%

BBIO 0.73%

BCAB 3.27%

BCDA -2.07%

BCDAW -41.77%

BCEL 0.00%

BCLI 2.60%

BCRX 1.32%

BCTX 8.12%

BCTXW -17.15%

BCYC 0.55%

BDRX -5.95%

BDTX -0.85%

BEAM -0.02%

BFRA -2.91%

BGNE -2.19%

BIOR -1.72%

BIVI 0.56%

BLCM -6.68%

BLI -5.88%

BLPH 0.00%

BLRX -0.85%

BLTE -0.62%

BLU 0.03%

BLUE -0.81%

BMEA -9.63%

BMRN 0.28%

BNOX -2.22%

BNTC -2.11%

BNTX -1.11%

BOLD -8.80%

BOLT -0.19%

BPMC -1.45%

BPTH 1.86%

BPTS -13.47%

BRNS -0.74%

BRTX -2.38%

BTAI 25.53%

BTTX 53.33%

BTX 0.05%

BVXV 0.74%

BXRX 7.39%

BYSI 3.33%

CABA 0.76%

CADL -1.23%

CALA 0.00%

CALC -1.77%

CALT -0.59%

CAPR -2.80%

CARA 0.85%

CARM 12.18%

CASI -1.67%

CATB -6.97%

CBAY 0.03%

CBIO -2.65%

CBLI -7.31%

CBUS -7.00%

CCCC -5.47%

CCXI 0.00%

CDAK 0.00%

CDIO -3.09%

CDIOW 24.00%

CDMO -2.82%

CDMOP 0.04%

CDT -10.57%

CDTTW -39.60%

CDTX -1.92%

CDXC -0.41%

CDXS 4.31%

CELC -3.56%

CELU -1.50%

CELUW 11.80%

CERC -1.68%

CERE -0.78%

CERO -3.60%

CEROW -10.18%

CFRX -27.95%

CGEM -2.62%

CGEN -3.31%

CGON -0.13%

CGTX -4.55%

CHMA -6.00%

CHRS -0.63%

CINC 0.00%

CING 0.70%

CINGW 34.95%

CKPT -2.89%

CLBS -16.75%

CLDX -2.32%

CLGN 0.34%

CLLS -4.15%

CLNN 2.43%

CLNNW 0.00%

CLRB 6.64%

CLSD -2.90%

CLSN -0.68%

CLVS 0.00%

CMMB -0.01%

CMND 3.63%

CMPI 0.00%

CMPX -10.42%

CMRA 0.00%

CMRAW 33.33%

CMRX -2.71%

CNCE 0.00%

CNSP -40.87%

CNST 0.00%

CNTA -0.67%

CNTB -2.25%

CNTX -6.85%

COCP -2.02%

COEPW 32.45%

COGT -3.01%

CORT 2.07%

COYA -1.46%

CPRX -0.53%

CRBP -2.11%

CRBU -5.11%

CRDF -2.21%

CRGX 1.34%

CRIS -0.38%

CRNX -5.95%

CRSP 0.97%

CRTX 2.63%

CRVO -2.50%

CRVS 1.12%

CSBR -1.59%

CTCX -1.63%

CTIC 0.06%

CTMX -2.90%

CTNM -1.02%

CTXR 1.13%

CUE 3.46%

CVAC -1.98%

CVKD 0.15%

CWBR 2.80%

CYAD -12.96%

CYCC 8.81%

CYCCP 5.49%

CYCN 0.43%

CYT -2.27%

CYTK -2.04%

CYTO -2.73%

DARE 6.54%

DAWN 0.30%

DBTX -0.81%

DBVT -2.08%

DFFN 10.28%

DICE 0.06%

DMAC 33.64%

DNLI -2.05%

DNTH -6.09%

DOMH -1.58%

DRMA -1.10%

DRMAW -1.25%

DRNA 0.00%

DRTS 1.85%

DRTSW 0.00%

DRUG 0.95%

DSGN -1.52%

DTIL 0.89%

DYAI 9.68%

EARS -1.77%

EDIT -2.46%

EDSA -1.00%

EFTR 7.18%

EFTRW -51.85%

EIGR -9.21%

ELAB -1.00%

ELDN 7.98%

ELEV -5.39%

ELOX 7.69%

ELTX -0.88%

ELVN -4.52%

ELYM 1.12%

ENGN 1.67%

ENGNW 0.12%

ENLV 2.54%

ENOB 1.79%

ENSC 5.11%

ENTA -0.49%

ENTO -0.07%

ENTX 0.69%

ENVB 1.10%

EPIX -0.10%

EPRX -2.97%

EPZM 0.00%

EQ 0.86%

EQRX -2.09%

EQRXW 0.00%

ERAS -1.20%

ERNA 0.00%

ERYP 1.30%

ESLA 4.30%

ESLAW 87.05%

ETNB -0.38%

ETON -0.30%

ETTX 0.00%

EVAX -2.14%

EVGN 6.35%

EVLO 0.00%

EWTX -0.03%

EXAI -0.57%

EXEL -0.27%

EYEG -0.69%

EYEN 1.54%

EYPT 0.12%

FATE -8.06%

FBIO 0.59%

FBIOP 0.92%

FBLG -17.80%

FBRX -0.04%

FDMT -4.73%

FENC -1.29%

FGEN -4.28%

FHTX 1.43%

FIXX 0.77%

FMTX 0.00%

FNCH 8.87%

FOLD -2.48%

FREQ 4.76%

FRLN 0.15%

FRTX 0.00%

FSTX 0.00%

FTRE -0.69%

FULC -3.51%

FUSN 0.00%

FWBI 4.59%

FWP 0.00%

GALT -6.71%

GANX -1.42%

GBIO -2.12%

GBT 0.01%

GDTC 0.50%

GERN -3.65%

GHRS -2.85%

GLMD 0.31%

GLPG -2.30%

GLSI 2.80%

GLTO -1.20%

GLUE -1.58%

GLYC -9.50%

GMAB -0.43%

GMDA -18.25%

GMTX 0.00%

GNCA -85.71%

GNFT -0.52%

GNLX 0.89%

GNPX 0.98%

GNTA 3.94%

GOSS -7.81%

GOVX 3.64%

GOVXW -49.04%

GPCR -7.14%

GRAY -10.80%

GRCL 0.05%

GRNA -0.03%

GRNAW 8.91%

GRPH -2.75%

GRTS -0.31%

GRTX 0.00%

GTHX 0.00%

GUTS -4.87%

GXGXW 41.67%

GYRE -6.02%

HALO -0.76%

HARP 0.09%

HCWB -3.75%

HEPA 2.80%

HGEN -84.62%

HILS 5.66%

HLVX -1.91%

HOOK 1.13%

HOTH -2.70%

HOWL -2.55%

HRMY 1.10%

HRTX 1.97%

HSTO 0.00%

HUMA 1.12%

HUMAW -0.01%

IBRX -4.12%

ICCC 0.22%

ICPT 0.21%

ICU 16.67%

ICUCW 20.20%

ICVX -0.91%

IDRA -23.04%

IDYA -1.50%

IFRX -2.66%

IGMS -0.11%

IKNA 0.60%

IKT 1.42%

IMAB -0.58%

IMCR -2.61%

IMGN 0.02%

IMGO 0.00%

IMMP 4.55%

IMMX -7.76%

IMNM -1.65%

IMNN 0.88%

IMPL -27.27%

IMRA 15.96%

IMRN -1.18%

IMRX -0.84%

IMTX -1.75%

IMTXW 6.00%

IMUX 1.56%

IMV 0.00%

IMVT -3.63%

INAB 0.59%

INBX 0.46%

INCY -0.84%

INDP 11.07%

INFI -52.38%

INKT -0.01%

INM -2.20%

INMB 2.80%

INO -1.95%

INSM -0.77%

INTS -2.75%

INVA 0.22%

INZY 0.92%

IOBT -11.02%

IONS -0.26%

IOVA -2.31%

IPA 2.46%

IPHA 5.58%

IPSC -1.95%

IRON -2.39%

ISEE 0.38%

ITOS -1.57%

ITRM 1.67%

IVA 6.96%

IVVD -4.13%

JAGX 1.04%

JANX -4.08%

JAZZ -0.54%

JNCE 0.00%

JSPR -6.20%

JSPRW 20.88%

JUNS 0.00%

JUNSW 0.00%

KA -3.94%

KALV -1.99%

KDNY 0.22%

KMPH -0.34%

KNSA -2.95%

KNTE -0.38%

KOD -6.72%

KPRX 0.96%

KPTI -1.38%

KRBP -10.00%

KRON 1.05%

KROS -1.18%

KRRO -9.25%

KRTX 0.03%

KRYS -0.89%

KTRA 16.73%

KTTA 8.16%

KTTAW 0.92%

KURA -1.93%

KYMR -2.15%

KYTX -3.62%

KZIA 5.16%

KZR -1.49%

LABP 0.57%

LBPH -0.89%

LBPS 0.00%

LBPSW 14.81%

LEGN 1.86%

LENZ -4.07%

LEXX 0.00%

LEXXW -14.63%

LGND -1.30%

LGNDV 0.00%

LGVN -8.53%

LIAN -8.28%

LIFE 2.70%

LIPO -7.10%

LIXT -5.24%

LIXTW 63.57%

LJPC -0.32%

LMNL 0.12%

LOGC 0.52%

LPCN -5.03%

LPTX -1.65%

LQDA -0.24%

LRMR -1.92%

LSTA -4.06%

LTRN 0.25%

LUMO -1.32%

LVTX 0.00%

LXEO -4.86%

LXRX -2.06%

LYEL -35.63%

LYRA 3.29%

MACK 0.10%

MBIO -9.36%

MBRX -1.74%

MCRB 1.36%

MDGL -2.31%

MDNA -13.16%

MDWD 0.10%

MDXG -2.58%

MEIP -0.13%

MESO -1.78%

MGNX -3.03%

MGTA -7.74%

MGTX -2.61%

MGX -2.68%

MIRM -1.42%

MIRO 0.59%

MIST 1.54%

MITO 0.00%

MLEC -7.69%

MLECW 2.31%

MLND -5.36%

MLTX -0.63%

MLYS -5.64%

MNKD -0.95%

MNMD 0.28%

MNOV 2.11%

MNPR -5.01%

MOLN 0.28%

MOR 1.06%

MORF -3.34%

MREO -4.29%

MRKR 2.68%

MRNA -4.76%

MRNS -4.03%

MRSN -2.62%

MRTX -0.17%

MRUS 0.26%

MRVI -1.96%

MTCR -1.29%

MTEM 4.46%

MTP -18.50%

MURA -0.93%

MYMD 8.38%

NAMS 1.09%

NAMSW 0.43%

NAUT 1.55%

NBRV 0.71%

NBSE -1.56%

NBTX 8.61%

NCNA 1.09%

NERV -1.87%

NEXI 2.60%

NGM -1.28%

NGNE -1.40%

NKGN 5.88%

NKGNW 8.00%

NKTR -4.21%

NKTX -4.57%

NLSP -2.77%

NLSPW 26.67%

NMRA -0.74%

NMTR -42.97%

NOVN -24.84%

NRBO 12.16%

NRIX -0.89%

NRSN -3.63%

NRSNW 0.00%

NRXP -5.39%

NRXPW 18.33%

NRXS 4.82%

NTBL 5.06%

NTEC -12.45%

NTHI 0.00%

NTLA -6.31%

NTRBW -31.07%

NUVL -2.12%

NVAX -1.22%

NVCT 3.94%

NVIV -34.28%

NXTC -2.95%

NYMX -0.05%

OABI 0.40%

OABIW -10.06%

OBIO -3.21%

OBSV 0.00%

OCEA 0.00%

OCGN 4.26%

OCS -1.02%

OCUL -1.91%

OCUP 1.63%

ODT -4.27%

OKYO 1.51%

OLMA -5.63%

OMER -0.77%

OMGA 6.25%

ONCO 7.71%

ONCR -3.08%

ONCS 31.87%

ONCT -1.87%

ONCY 0.99%

ONTX -0.47%

ONVO 0.99%

OPNT 0.00%

OPT 1.03%

ORGS -4.53%

ORIC -3.56%

ORMP 15.18%

ORPH 0.00%

ORTX 0.30%

OSMT -1.77%

OTIC -92.64%

OTLK -1.81%

OVID -1.43%

OYST 0.00%

PALI -0.87%

PASG -1.31%

PBLA -7.50%

PBM -7.29%

PBYI 1.01%

PCSA 0.00%

PCVX -0.23%

PDSB -0.63%

PEPG 1.55%

PGEN -3.59%

PHAR 1.51%

PHAS 0.00%

PHAT -1.26%

PHIO -3.62%

PHIOW 36.47%

PHVS -7.22%

PHXM -5.20%

PIRS 0.58%

PKBO 0.00%

PKBOW 999 900.00%

PLRX -0.64%

PLUR 6.01%

PMN 0.72%

PMVP -1.19%

PNT 0.16%

PPBT 0.28%

PRAX 0.60%

PRDS 0.93%

PRLD 0.00%

PROG -3.47%

PROK 0.89%

PRQR -0.01%

PRTA -2.34%

PRTC 0.49%

PRTG -0.50%

PRTK 1.83%

PRVB 0.00%

PSTI -2.91%

PSTV -5.11%

PSTX -1.17%

PTCT -0.17%

PTE -0.82%

PTGX -1.89%

PTIXW -49.04%

PULM 2.62%

PXMD 0.00%

PYPD 0.07%

PYXS 4.43%

QLGN -3.72%

QNCX 5.67%

QNRX 0.37%

QSI -11.62%

QSIAW -3.13%

QTTB -4.54%

QURE -0.22%

RAIN -1.63%

RANI 6.42%

RAPT -3.22%

RARE 1.26%

RCKT -8.18%

REGN -0.74%

RENB -3.42%

REPL -3.00%

RETA 0.02%

REUN -0.89%

REVB -0.47%

REVBU 3.46%

REVBW 4.38%

RGLS -4.67%

RGNX -5.20%

RIGL -3.28%

RLAY -4.60%

RLMD 0.33%

RLYB -0.33%

RNA -0.44%

RNAC -5.65%

RNAZ -0.95%

RNXT 1.88%

ROIV -2.08%

ROIVW 4.56%

RPHM -0.31%

RPRX 0.30%

RPTX -2.05%

RUBY 2.70%

RVLP -32.05%

RVMD -1.29%

RVMDW -30.00%

RVNC 1.70%

RVPH -1.02%

RVPHW 1.62%

RXDX 0.09%

RXRX -3.52%

RYTM -6.24%

RYZB 0.02%

RZLT 1.29%

SABS -1.37%

SABSW -11.81%

SAGE 1.47%

SANA -4.25%

SAVA -0.26%

SAVAW 0.00%

SBBP 1.52%

SBTX 1.03%

SCNI 5.50%

SCPH -0.25%

SCPS 0.00%

SEEL -4.09%

SEER -0.44%

SELB -8.00%

SESN 7.29%

SGEN -0.07%

SGMO -1.01%

SGMT -1.69%

SGTX -2.56%

SIOX 22.63%

SLDB -4.73%

SLGL 4.00%

SLN -4.21%

SLNO -2.39%

SLRX 5.91%

SLS -2.99%

SMMT -2.50%

SNDX 0.61%

SNGX -3.02%

SNPX -0.81%

SONN -1.08%

SPPI -0.49%

SPRB 0.30%

SPRC -4.17%

SPRO 0.04%

SRNE -31.19%

SRPT -1.30%

SRRA 0.00%

SRRK -2.48%

SRZN -2.45%

STAB 0.00%

STOK -4.89%

STRO -2.84%

STSA 0.00%

STTK -4.78%

SURF -0.93%

SVRA -3.16%

SWTX 0.33%

SYBX -1.94%

SYRS -1.72%

TALS -0.73%

TARA -7.94%

TARS 0.08%

TBPH 0.36%

TCBP 0.00%

TCDA 0.00%

TCON -2.43%

TCRR 0.00%

TCRT 1.59%

TCRX 2.67%

TECH -0.07%

TENX -1.27%

TERN -6.34%

TFFP -3.05%

TGTX -2.97%

THRX 0.12%

TIL -0.20%

TLC 0.00%

TLSA -4.13%

TNGX -2.59%

TNXP -5.34%

TNYA -8.92%

TPST 2.39%

TRDA -3.86%

TRVI 0.77%

TRVN 5.02%

TSHA -23.76%

TSVT -3.06%

TTNP -9.27%

TVTX 0.50%

TYRA -8.19%

UBX -0.96%

UNCY -3.39%

URGN -1.58%

UTHR -0.45%

VACC 11.36%

VALN -2.89%

VAXX 87.50%

VBIV 0.78%

VBLT -8.77%

VCEL 0.29%

VCNX 10.35%

VCYT -1.23%

VERA -2.78%

VERU 0.73%

VERV -2.68%

VIGL 6.18%

VINC 1.62%

VIR 0.84%

VIRI -1.61%

VIRX 3.33%

VKTX -1.00%

VLON -13.04%

VNDA -2.36%

VOR -1.63%

VRCA 0.28%

VRDN -3.84%

VRNA -1.20%

VRPX 0.38%

VRTX 0.10%

VSTM -3.40%

VTGN -0.46%

VTVT -2.97%

VTYX -0.21%

VXRT -1.68%

VYGR -1.66%

VYNE -3.47%

VYNT 7.78%

WINT -3.24%

WVE -4.61%

XBIO 0.93%

XBIT 1.46%

XCUR 3.61%

XENE -3.05%

XERS 2.14%

XFOR 3.73%

XLO 4.43%

XLRN 0.00%

XNCR 0.05%

XOMA -3.14%

XOMAO 0.36%

XOMAP -0.82%

XRTX -9.85%

YMAB -1.80%

ZGNX 0.00%

ZIOP -0.88%

ZLAB -3.24%

ZNTL -2.97%

ZSAN 0.00%

Insider Trading

Date	Person	Action	Amount	type
2022-08-22	Rosen Robert	Sell	30 000	Stock Option (Right to Buy)
2022-08-22	Rosen Robert	Sell	18 000	Stock Option (Right to Buy)
2022-08-22	Rosen Robert	Sell	10 000	Stock Option (Right to Buy)
2022-08-22	Rosen Robert	Sell	10 000	Stock Option (Right to Buy)
2022-08-22	Rosen Robert	Sell	10 000	Stock Option (Right to Buy)

INSIDER POWER
-100.00
Last 100 transactions
Buy: 0 \| Sell: 11 680 911

मात्रा सहसंबंध

लंबा: 0.33 (neutral)

छोटा: -0.74 (moderate negative)

Signal:(78.937) Neutral

La Jolla Pharmaceutical सहसंबंध

10 सबसे अधिक सकारात्मक सहसंबंध

10 सबसे अधिक नकारात्मक सहसंबंध

क्या आप जानते हैं?

कोरलेशन एक सांख्यिकीय माप है जो दो चरों के बीच संबंध का वर्णन करता है। यह -1 से 1 तक का होता है, जहाँ -1 एक पूर्ण नकारात्मक कोरलेशन को दर्शाता है (जैसे ही एक चर बढ़ता है, दूसरा कम होता है), 1 एक पूर्ण सकारात्मक कोरलेशन को दर्शाता है (जैसे ही एक चर बढ़ता है, दूसरा भी बढ़ता है) और 0 कोई कोरलेशन नहीं होता है (चरों के बीच कोई संबंध नहीं है)।

कोरलेशन किसी भी दो चरों के बीच संबंध का विश्लेषण करने के लिए इस्तेमाल किया जा सकता है, न कि केवल स्टॉक में। यह वित्तीय, अर्थशास्त्र, मनोविज्ञान और अन्य क्षेत्रों में आमतौर पर उपयोग किया जाता है।

La Jolla Pharmaceutical सहसंबंध - मुद्रा/वस्त्र

0.29
( neutral )

-0.63
( weak negative )

0.77
( moderate )

0.37
( neutral )

-0.47
( neutral )

-0.54
( weak negative )

La Jolla Pharmaceutical वित्तीय

Annual	2021
राजस्व:	$75.72M
सकल लाभ:	$62.23M (82.19 %)
EPS:	$0.720

FY	2021
राजस्व:	$75.72M
सकल लाभ:	$62.23M (82.19 %)
EPS:	$0.720

FY	2020
राजस्व:	$33.42M
सकल लाभ:	$25.60M (76.60 %)
EPS:	$-1.440

FY	2019
राजस्व:	$23.05M
सकल लाभ:	$20.66M (89.62 %)
EPS:	$-4.30

Financial Reports:

No articles found.

La Jolla Pharmaceutical Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

La Jolla Pharmaceutical

La Jolla Pharmaceutical Company engages in the development and commercialization of therapies that improve outcomes in patients suffering from life-threatening diseases. The company offers GIAPREZA, a vasoconstrictor indicated to increase blood pressure in adults with septic or other distributive shock; and XERAVA, a tetracycline class antibacterial indicated for the treatment of complicated intra-abdominal infections in patients 18 years of age and older. It offers GIAPREZA and XERAVA to hospitals and other healthcare organizations in the United States. Its product candidates that are in early stage clinical or preclinical development include TP-6076, an IV formulation of a fully synthetic fluorocycline derivative for the treatment of certain multidrug-resistant gram-negative bacteria; TP-271, an IV and oral formulation of a fully synthetic fluorocycline for the treatment of respiratory disease caused by bacterial biothreat and antibiotic-resistant public health pathogens, as well as bacterial pathogens associated with community-acquired bacterial pneumonia; and TP-2846, an IV formulation of a tetracycline for the treatment of acute myeloid leukemia. The company has license agreement with Everest Medicines Limited to develop and commercialize XERAVA; and PAION AG to commercialize GIAPREZA and XERAVA. La Jolla Pharmaceutical Company was incorporated in 1989 and is based in Waltham, Massachusetts. As of August 22, 2022, La Jolla Pharmaceutical Company operates as a subsidiary of Innoviva, Inc.